MedTrace Logo

Postoperative Symptoms in Chinese Liver Cancer Patients: Network Analysis

NCT06419478 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 249

Last updated 2024-05-17

No results posted yet for this study

Summary

Patients with primary liver cancer (PLC) experience a range of symptoms in the early postoperative period. Symptoms include cancer-related symptoms and adverse effects of treatment. Exploring the core symptoms and their dynamics in the early post-hepatectomy patients may help provide better symptom management programs. The purpose of this study was to identify the core symptoms in early post-hepatectomy patients and to explore the trajectory of their dynamics. During the period from March 2021 to September 2022, a total of 281 patients diagnosed with PLC and undergoing radical curative surgery were recruited from the hepatobiliary surgery departments of two hospitals in Eastern China, among whom 249 individuals (88.60%) agreed to participate in the study. A comprehensive symptom assessment was administered to the patients 1-2 days after surgery (T1) and 1-2 days before discharge (T2). Network analysis was used to identify core symptoms in early post-hepatectomy patients based on symptom severity.

Conditions

  • Patients With Primary Liver Cancer (PLC) Undergoing Curative Surgical Procedures
  • Importance of Identifying Core Symptoms for Improving Symptom Management in PLC Patients
  • Application of Network Analysis as a Crucial Component of Cancer Care

Interventions

OTHER

postoperative symptoms

Observational study, focusing solely on symptom surveys of patients.

Sponsors & Collaborators

  • Anhui Medical University

    collaborator OTHER

  • Mengmeng Yuan

    lead OTHER

Principal Investigators

  • shuwen M Li, PhD · Anhui Medical University

Eligibility

Min Age
40 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2022-08-31
Completion
2022-09-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06419478 on ClinicalTrials.gov